Home / Comparisons /
Modafinil vs caffeine
This page is a reference summary of published evidence and regulatory documents. It is not a substitute for individual medical advice, and it is not a recommendation to take or avoid any medicine.
Medically reviewed by Dr. Sofia Lindqvist, · Last reviewed 11 August 2026
Modafinil has an elimination half-life around 15 hours, roughly three times caffeine’s approximately 5 hours, so a single modafinil dose covers a working day in a way a single cup of coffee does not. Both drugs show their largest measured effects in people who are sleep-deprived rather than already well rested, which is a genuine similarity rather than a marketing claim for either.
The practical difference that matters most day to day is regulatory: modafinil requires a prescription in most countries, while caffeine is available without restriction.
On this page
Comparison table
| Modafinil | Caffeine | |
|---|---|---|
| Half-life | ~15 hours | ~5 hours (range 1.5-9.5h, varies with CYP1A2 genotype) |
| Mechanism | DAT inhibition; wake-promoting agent | Adenosine receptor antagonism |
| Typical effective dose | 100-400mg | 100-400mg/day, effective single dose ~200mg |
| Tolerance | Not well characterized; limited long-term repeated-dosing data | Develops within days for alerting and cardiovascular effects |
| Regulatory status | Prescription-only, Schedule IV (US) | Unregulated food/supplement ingredient |
| Withdrawal on stopping | Not well documented | Headache, fatigue, irritability, well documented |
Mechanism difference
Caffeine works by blocking adenosine A1 and A2A receptors, preventing the buildup of adenosine, a molecule that accumulates during wakefulness and promotes sleepiness, from suppressing arousal circuits. Modafinil inhibits the dopamine transporter and engages downstream orexinergic and histaminergic wake-promoting pathways. These are unrelated mechanisms that happen to converge on the same outcome, increased wakefulness, which is part of why some evidence suggests their effects may combine rather than simply overlap, though this has not been rigorously tested.
Where they differ
Duration is the clearest difference: modafinil’s ~15-hour half-life means a morning dose remains pharmacologically active into the evening, while caffeine’s ~5-hour half-life (with substantial individual variation driven by CYP1A2 genotype) means effects fade within a working afternoon.
Tolerance also diverges sharply. Regular caffeine users develop measurable tolerance to its alerting and blood-pressure effects within days of continued use, and abrupt cessation produces a well-documented withdrawal syndrome: headache, fatigue, and irritability, typically peaking at 24-48 hours. Modafinil’s tolerance and withdrawal profile is comparatively understudied with repeated daily use, and clinically significant withdrawal is not well documented in the literature.
Where they are the same
Military-funded studies of sustained sleep deprivation have tested both compounds and found broadly comparable improvements in vigilance and reaction-time tasks at standard doses, with modafinil’s benefit persisting longer due to its longer half-life.
Both drugs show a consistent pattern in the cognitive-enhancement literature: effects on alertness and psychomotor performance are largest in sleep-deprived subjects and small or negligible in well-rested subjects performing simple tasks. Neither drug reliably improves complex cognitive performance in rested, healthy people beyond restoring performance lost to sleep loss.
Who each tends to suit
Caffeine is the practical default for routine daytime alertness given its availability, low cost, and well-characterized safety profile at moderate intake. Modafinil is reserved for diagnosed sleep disorders or specific circumstances such as sustained operational sleep deprivation, where its longer duration and prescription oversight are relevant considerations, not casual daily use.
Does caffeine work as well as modafinil for sleep deprivation?
In several military and laboratory studies of sustained sleep deprivation, standard caffeine doses (200-300mg) and modafinil (200-400mg) produced broadly comparable improvements in vigilance and reaction time, though modafinil’s effect lasted longer given its longer half-life.
Why does caffeine seem to stop working over time?
Regular caffeine use produces measurable tolerance to its alerting and cardiovascular effects within days, driven partly by adenosine receptor upregulation. Modafinil’s tolerance profile in the alertness-promoting effect is not well characterized by comparable adaptation, though evidence on long-term repeated dosing is limited.
Is it safe to combine modafinil and caffeine?
This combination has not been systematically studied for safety or added benefit. Both increase heart rate and can worsen insomnia when combined, so caution is warranted, particularly with high caffeine intake.
Why is one a supplement and the other a prescription drug?
Caffeine’s safety margin at typical dietary doses and its long history of unsupervised use place it outside prescription regulation. Modafinil’s prescription status reflects its more potent pharmacology, potential for drug interactions via liver enzymes, and a documented risk of serious skin reactions.
References
- 1. FDA. Provigil (modafinil) prescribing information.
- 2. Wesensten NJ, et al. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology. 2002.
- 3. Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018.
- 4. Juliano LM, Griffiths RR. A critical review of caffeine withdrawal. Psychopharmacology. 2004.